CytoDyn Inc (OTCPK:CYDY)
$ 0.1148 -0.0021 (-1.8%) Market Cap: 140.04 Mil Enterprise Value: 144.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Cytodyn Inc Leronlimab For COVID-19 Coronavirus Treatment Transcript

May 02, 2020 / NTS GMT
Jack Marks;Nader Pourhassan
Wall Street Reporter - Analyst;Cytodyn Inc - President &

Good afternoon, everybody, and welcome to Wall Street Reporter's Next Super Stock livestream for today, May 1, 2020. We have another special presentation today from CytoDyn, the stock many of you have been following since they first presented at our live stream back in August. The stock is up tremendously, making new highs every day this week.

And today, we're going to find out what's going to be next for the company, and if this is just the start of even bigger things to come. So, we're going to have Dr. Bruce Patterson joining; we have, of course, Dr. Nader Pourhassan, the COE. And we have a lot of questions that came in. We have, I think, over 200 questions that just came in from people who have registered up until this morning. So hopefully, we'll get to address part of them. So, again [forward] is going to be simple; Nader is going to present; then we'll turn over I think to Bruce; and we'll open up for Q&A.

So with that said, Nader, I will turn it over to you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot